Number of Rotavirus (RV) Related Hospitalizations in Belgium - Season 2010-2011
NCT01563159 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1
Last updated 2018-03-14
Summary
This study aims to confirm the statistically significant decline in rotavirus related and in acute gastro-enteritis (AGE) related hospital admissions that was observed in 11 participating hospitals, after the introduction of RV vaccines in Belgium in 2006.
Conditions
- Infections, Rotavirus
Interventions
- OTHER
-
Data collection
Each participating centre will be requested to generate a coded list of all stool samples taken during the study period (June 1st 2010- May 31st 2011) and analysed for rotavirus, in children aged ≤5 years.
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
GSK Clinical Trials · GlaxoSmithKline
Eligibility
- Max Age
- 5 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-03-31
- Primary Completion
- 2017-12-31
- Completion
- 2017-12-31
More Related Trials
-
Vaccine Effectiveness of RV1 in a Naïve Population
NCT01467037 ·Status: COMPLETED
-
Study to Assess the Impact of Vaccination on Hospitalizations and Outpatient Visits Due to Rotavirus Gastroenteritis
NCT01733862 ·Status: COMPLETED
-
Impact of Systematic Infants Vaccination Against Rotavirus on Gastroenteritis Hospitalization: a Prospective Study in Brest District, France.
NCT00740935 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Rotavirus Vaccination on Hospital Pressures at a Large Paediatric Hospital in the UK: an Ecological Study
NCT03271593 ·Status: COMPLETED
-
The Epidemiology and Etiology of Acute Gastroenteritis Among Estonian Children After Introduction of Rotavirus Vaccines
NCT02662543 ·Status: UNKNOWN
-
Study to Evaluate the Effectiveness of Rotarix™ Against Severe Gastroenteritis Among Hospitalized Children in Brazil
NCT01177657 ·Status: COMPLETED
-
Surveillance Study to Estimate the Proportion of Rotavirus Gastroenteritis in Children < 5 Years of Age in Romania
NCT01253967 ·Status: COMPLETED
-
Impact of Rotavirus Vaccination on Hospitalisations for Rotavirus Gastroenteritis in Children Aged <5 Years in Australia
NCT01236066 ·Status: COMPLETED
-
Canadian Rotavirus Surveillance Through the Immunization Monitoring Program Active (IMPACT)
NCT01633190 ·Status: UNKNOWN
-
Effectiveness of Rotarix™ Against Rotavirus Severe Gastroenteritis (RV SGE) in Infants in Panama
NCT00653198 ·Status: COMPLETED
-
Study to Analyze the Clinical and Cost Impact of Complete and Incomplete Rotavirus (RV) Vaccination
NCT01682005 ·Status: COMPLETED
-
Study to Analyze the Clinical and Cost Impact of Complete and Incomplete Rotarix Vaccination
NCT01915888 ·Status: COMPLETED
-
Effectiveness of Monovalent Rotavirus Vaccine (RV1)
NCT01871038 ·Status: COMPLETED
-
Surveillance of Rotavirus Gastroenteritis in Children <5 Years
NCT01363726 ·Status: UNKNOWN
-
Rotavirus Burden and Genotypes in a Sentinel Hospital Surveillance System in Lebanon
NCT01321216 ·Status: COMPLETED
-
Effectiveness of Human Rotavirus Vaccine, Rotarix™ Against Rotavirus Severe Gastroenteritis (RV SGE) in Infants
NCT00655187 ·Status: COMPLETED
-
Effectiveness of RotarixTM Vaccine in Children Aged Between 12 Weeks to < 5 Years, Hospitalised for Severe Gastroenteritis
NCT01978223 ·Status: WITHDRAWN
-
Hospital-based Surveillance to Collect Prospective Data to Estimate the Disease Burden of Severe RV GE in Sweden
NCT00489567 ·Status: COMPLETED
-
Improving Rotavirus Vaccine Immune Response
NCT01825109 ·Status: COMPLETED ·Phase: PHASE3
-
The Efficacy of Three Doses of Live Attenuated, Oral Rotavirus Vaccine 116E
NCT05958771 ·Status: UNKNOWN ·Phase: PHASE3
-
Rotavirus Gastroenteritis and Vaccine Usage in Rhode Island
NCT01026779 ·Status: COMPLETED
-
Glycan Attachment Specificity, Toward ROtavirus Vaccine IMprovement GASTROVIMc (Clinical Investigation)
NCT02902445 ·Status: COMPLETED
-
Human Challenge With Live-attenuated Rotavirus to Assess Next-generation Rotavirus Vaccines in Africa
NCT04658914 ·Status: COMPLETED ·Phase: PHASE2
-
Year 3 Extension for Efficacy Follow-up in Subjects Vaccinated in Studies Rota-028, 029 or 030 (NCT00197210)
NCT00329745 ·Status: COMPLETED ·Phase: PHASE3
-
Special Drug Use Investigation for ROTARIX®
NCT01636739 ·Status: COMPLETED